10X Genomics Inc Class A (TXG)
EBITDA Margin
6.11%
TTM · Period ending:
TXG EBITDA Margin
Latest reported6.11%period ending
Latest reported6.11%period ending
TXG TTM EBITDA Margin (-73.47% → 6.11%)
TTM ebitda margin
High-resolution chart · PNG
TXG ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 6.1059% | |
| 14.6059% | |
| 10.9742% | |
| -4.8001% | |
| -5.9806% | |
| -17.8292% | |
| -21.937% | |
| -20.811% | |
| -29.7108% | |
| -33.6399% | |
| -33.1505% | |
| -30.1264% | |
| -22.7872% | |
| -25.3483% | |
| -24.8812% | |
| -25.6353% | |
| -21.3834% | |
| -10.7698% | |
| -5.0144% | |
| -91.2572% | |
| -115.8172% | |
| -150.9423% | |
| -171.9196% | |
| -43.5529% | |
| -24.2449% | |
| -13.6526% | |
| -8.96% | |
| -42.3394% | |
| -51.6189% | |
| -55.491% | |
| -73.4656% |